Late-Breaking BIOTRONIK Study Results To Be Presented At Congress 2017 Post author:Sam Post published:August 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like OPKO Health’s Annual Report a Mixed Bag March 1, 2018 Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017 Kamada, Chiesi Farmaceutici Terminate Inhaled Alpha-1 Antitrypsin Therapy Deal November 19, 2017
Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017